These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3259480)

  • 1. Thymostimulin treatment in AIDS-related complex.
    Palmisano L; Chisesi T; Galli M; Gritti FM; Ielasi G; Lazzarin A; Mezzaroma I; Moroni M; Raise E; Vaglia A
    Clin Immunol Immunopathol; 1988 Jun; 47(3):253-61. PubMed ID: 3259480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymostimulin treatment in cases of AIDS and ARC.
    Raise E; Bonazzi L; Di Giandomenico G; Sabbatini S; Schiattone ML; Di Pede B; Gallo R; Savoia M; Martuzzi M
    J Exp Pathol; 1987; 3(4):745-50. PubMed ID: 3454812
    [No Abstract]   [Full Text] [Related]  

  • 3. A double-blind, placebo-controlled trial of thymostimulin in symptomatic HIV-infected patients.
    Beall G; Kruger S; Morales F; Imagawa D; Goldsmith JA; Fisher D; Steinberg J; Phair J; Whaling S; Bitran J
    AIDS; 1990 Jul; 4(7):679-81. PubMed ID: 1975746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapeutic use of thymostimulin in HIV-seropositive subjects and with lymphadenopathy syndrome].
    Carcò F; Guazzotti G
    Recenti Prog Med; 1993 Nov; 84(11):756-64. PubMed ID: 8290787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin requirements and residual beta-cell function 12 months after concluding immunotherapy in type I diabetic patients treated with combined azathioprine and thymostimulin administration for one year.
    Moncada E; Subirá ML; Oleaga A; Goñi F; Sánchez-Ibarrola A; Monreal M; Sevilla M; Goñi MJ; Yoldi A; Terán D
    J Autoimmun; 1990 Oct; 3(5):625-38. PubMed ID: 2252531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increase of OKT4+ cells during treatment with thymostimulin in parenteral drug addicts with persistent generalized lymphadenopathy.
    Lazzarin A; Galli M; Moriondo P; Parravicini C; Poli G; Moroni M
    J Clin Lab Immunol; 1986 Jun; 20(2):57-61. PubMed ID: 2942692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T lymphocytes in children with recurrent respiratory infections: effect of the use of thymostimulin on the alterations of T-cell subsets.
    De Martino M; Rossi ME; Muccioli AT; Vierucci A
    Int J Tissue React; 1984; 6(3):223-8. PubMed ID: 6332795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymostimulin therapy in melanoma patients: correlation of immunologic effects with clinical course.
    Bernengo MG; Fra P; Lisa F; Meregalli M; Zina G
    Clin Immunol Immunopathol; 1983 Sep; 28(3):311-24. PubMed ID: 6603936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of a treatment with a thymus extract (thymostimulin) in acute viral hepatitis B in drug-dependent patients].
    Corridori S; Trespi G; Baldini E; Renzetti I; Calderon W
    Boll Ist Sieroter Milan; 1984; 63(6):519-28. PubMed ID: 6242017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunostimulation in heart surgery: thymostimulin. Preliminary data].
    Maccherini M; Davoli G; Sani G; Miraldi F; Gotti G; Toscano M
    Minerva Chir; 1993 Dec; 48(23-24):1445-8. PubMed ID: 8177449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of immunomodulating treatment (thymostimulin) in chronic obstructive pulmonary disease.
    Banos V; Gómez J; García A; Ruiz J; Alvarez R; Lorenzo M; Canteras M; Valdés M
    Respiration; 1997; 64(3):220-3. PubMed ID: 9154674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I/II trial of thymostimulin in opportunistic infections of the acquired immune deficiency syndrome.
    Chachoua A; Green MD; Valentine F; Muggia FM
    Cancer Invest; 1989; 7(3):225-9. PubMed ID: 2790539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro effect of a bovine thymic extract (thymostimulin) on T-cell differentiation in cord blood lymphocytes.
    Lin CY; Chu CM
    Pediatr Pharmacol (New York); 1985; 5(3):181-7. PubMed ID: 3879346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of thymostimulin on chemotherapy-induced changes in lymphocyte subset distribution. A longitudinal study in patients with primary inoperable oropharyngeal cancers].
    Schuff-Werner P; Löhr G; Rauschning W; Schröder M; Musil J; Nagel GA
    Onkologie; 1987 Jun; 10(3 Suppl):17-21. PubMed ID: 3309757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thymic factor therapy for herpetic keratitis.
    Pivetti-Pezzi P; De Liso P; Tamburi S; Luzi G; Sirianni MC; Palmisano L; Aiuti F
    Ann Ophthalmol; 1985 Jun; 17(6):327-31. PubMed ID: 3893286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled trial of a thymic hormone extract (Thymostimulin) in 'autoimmune' chronic active hepatitis.
    Hegarty JE; Nouri Aria KT; Eddleston AL; Williams R
    Gut; 1984 Mar; 25(3):279-83. PubMed ID: 6230296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of immunoglobulin preparation on course of AIDS-related complex (ARC).
    Ohno T; Kanoh T; Uchino H; Harada S
    Tohoku J Exp Med; 1988 Dec; 156(4):415-6. PubMed ID: 3266686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyper IgE syndrome: four case report.
    Pigatto PD; Polenghi MM; Altomare GF; Brugo AM; Tadini GL; Morelli M
    Boll Ist Sieroter Milan; 1984 Sep; 63(4):378-82. PubMed ID: 6549138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind placebo-controlled study of thymostimulin (TP-1) for the treatment of atopic eczema.
    Harper JI; Mason UA; White TR; Staughton RC; Hobbs JR
    Br J Dermatol; 1991 Oct; 125(4):368-72. PubMed ID: 1835403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thymostimulin in the antiinfectious treatment in patients with burns.
    Schiavon M; Chiarelli A; Löhr G; Mazzoleni F
    Arzneimittelforschung; 1987 May; 37(5):557-60. PubMed ID: 3497638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.